ZNTL 8-K: SEC filing
Filed with the SEC on · accession 0001725160-26-000069
ZNTL filed a 8-K (current report) with the SEC on Nov 9, 2026. Zentalis Pharmaceuticals furnished a press release announcing its financial results for the quarter ended September 30, 2026, along with business updates, and provided a corporate presentation for investor meetings.
Summary of the filing
Zentalis Pharmaceuticals furnished a press release announcing its financial results for the quarter ended September 30, 2026, along with business updates, and provided a corporate presentation for investor meetings. The filing is a routine earnings disclosure under Items 2.02 and 7.01.
Key details
✦ Ask GOAX AI about this filing — what it means for ZNTL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ZNTL?
Click hereFrequently asked questions
What did ZNTL file with the SEC on Nov 9, 2026?
ZNTL filed a 8-K (SEC filing). Zentalis Pharmaceuticals furnished a press release announcing its financial results for the quarter ended September 30, 2026, along with business updates, and provided a corporate presentation for investor meetings. The filing is a routine earnings disclosure under Items 2.02 and 7.01.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other ZNTL SEC filings
- SCHEDULE 13G/A · SEC filingOct 27, 2026
- SCHEDULE 13G/A · SEC filingAug 19, 2026
- 8-K · Secondary offeringAug 14, 2026
- 424B5 · Secondary offeringAug 14, 2026
- 424B5 · Secondary offeringAug 13, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingJun 18, 2026
- 8-K · SEC filingMay 27, 2026
Get alerts when ZNTL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days